## Distinguishing Circuit Dysfunction: STN Lesion vs. Parkinson Disease ### Pathophysiological Distinction **Key Point:** The best discriminating feature between STN lesion (hemiballismus) and Parkinson disease (bradykinesia/rigidity) is the **direction of GPi/SNr inhibitory output to the thalamus**: **reduced** inhibitory output in STN lesion versus **increased** inhibitory output in Parkinson disease. ### Comparative Circuit Analysis | Aspect | STN Lesion | Parkinson Disease | |--------|-----------|-------------------| | **Primary defect** | Loss of glutamatergic excitation to GPi/SNr | Dopamine depletion → indirect pathway overactivity | | **GPi/SNr output** | Markedly **reduced** (hypoactive) | Markedly **increased** (hyperactive) | | **Thalamic activity** | Excessive (disinhibited) | Suppressed (over-inhibited) | | **Motor phenotype** | Hyperkinetic (hemiballismus) | Hypokinetic (bradykinesia, rigidity) | ### Mechanistic Explanation **In STN Lesion (Hemiballismus):** 1. Unilateral STN damage → loss of glutamatergic (excitatory) drive to GPi and SNr 2. GPi/SNr neurons fire less frequently → **reduced inhibitory (GABAergic) output to thalamus** 3. Thalamus is disinhibited → excessive excitation of motor cortex 4. Result: involuntary, ballistic movements (hemiballismus) **In Parkinson Disease (Bradykinesia/Rigidity):** 1. Dopamine depletion → D1-mediated direct pathway underactive; D2-mediated indirect pathway overactive 2. Overactive indirect pathway (striatum → GPe → STN → GPi) drives STN hyperactivity 3. Hyperactive STN → excessive glutamatergic drive to GPi → **increased inhibitory (GABAergic) output to thalamus** 4. Thalamus is over-inhibited → reduced motor cortex excitation 5. Result: bradykinesia and rigidity ### Why Option C is the Best Discriminator Option C directly captures the **net output change at GPi/SNr** — the final common pathway of basal ganglia output — which is the clearest mechanistic discriminator between the two conditions. The direction of GPi inhibitory output (reduced vs. increased) directly explains the opposite motor phenotypes (hyperkinetic vs. hypokinetic). This is the core prediction of the DeLong (1990) basal ganglia model. **Why Option B is Incorrect as the Best Discriminator:** Option B states "loss of excitatory glutamatergic drive from STN to GPi in STN lesion versus preserved but dysregulated STN activity in Parkinson disease." While the first half is accurate, the second half ("preserved but dysregulated") is an incomplete and misleading characterization — STN activity is actually *hyperactive* in Parkinson disease, not merely dysregulated. More importantly, Option B focuses on an upstream node (STN-level changes) rather than the final basal ganglia output (GPi→thalamus), making it a less direct and less discriminating answer. **Why Options A and D are Incorrect:** - Option A incorrectly states "hyperactivity of the direct pathway in STN lesion" — the STN lesion primarily reduces GPi drive, not via direct pathway hyperactivity. - Option D is a downstream consequence (thalamic excitation change) rather than the primary circuit discriminator at the level of basal ganglia output. **High-Yield:** The basal ganglia model (DeLong, 1990) predicts that GPi/SNr output is the critical node: reduced output → hyperkinesia; increased output → hypokinesia. This is the basis for surgical interventions (pallidotomy, DBS of GPi or STN) in both conditions. **Clinical Pearl:** Deep brain stimulation of the STN in Parkinson disease reduces STN hyperactivity, thereby reducing GPi output and restoring thalamic excitability — directly reversing the increased inhibitory output described in Option C. [cite: DeLong MR, Science 1990; Harrison's Principles of Internal Medicine 21e Ch 428; Kandel & Schwartz Principles of Neural Science 6e Ch 43]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.